[
    [
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)：48.64万份“健帆JLC2”采用自主行权模式",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "48.64万份",
                    "健帆JLC2",
                    "自主行权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：48.64万份“健帆JLC2”采用自主行权模式",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)：134.16万份“健帆JLC3”采用自主行权模式",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "134.16万份",
                    "健帆JLC3",
                    "自主行权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：134.16万份“健帆JLC3”采用自主行权模式",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)：278.76万份“健帆JLC4”采用自主行权模式",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "278.76万份",
                    "健帆JLC4",
                    "自主行权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：278.76万份“健帆JLC4”采用自主行权模式",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股多数逆势下滑，恩捷、国瓷、泰格、健帆、广联达等跌幅居前",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "逆势下滑",
                    "恩捷",
                    "国瓷",
                    "泰格",
                    "健帆",
                    "广联达"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "科技",
                    "材料"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股多数逆势下滑，恩捷、国瓷、泰格、健帆、广联达等跌幅居前",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]